WASHINGTON — The Biden administration backed off some of its plans to rein in billions of dollars from wasteful spending in ...

The FDA inspection occurred shortly after Global Pharma Healthcare recalled two different brands of eye drops over ...

Amid treaty talks to create equitable access to medical products during pandemics, the European Union has proposed pricing ...

Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name drug makers increased their ...

"It tells you that when two groups of people with different ancestry get the same treatment for the same subtype of cancer, ...

Now experts say the government’s plans to end the Covid public health emergency on May 11 could further jeopardize the health and safety of trans people across the country. “These targeted political ...

Lisa Barnes runs one of the nation’s largest studies of Alzheimer’s disease focused exclusively on Black people and has ...

A federal judge Thursday reversed a major Obamacare provision requiring plans to cover preventive care ranging from cancer ...

The U.S.'s usual, reactive approach to disease — wait for it to spring up before starting the work — is not a sustainable ...

It looks like the Solicitor General is siding with Teva by requesting the Supreme Court” to review the case, said Aziz Burgy, ...

A new CDC study highlights just how violent the recent past has been in the U.S. by showing a surge in people wounded by ...

Prescription drug middlemen are shifting away from rebates to increasingly larger administrative fees and specialty-generic ...